- Ownership hops held
- 165
An absent edge means not yet observed — never does not exist.
Merus N.V.
Merus N.V. — US company (sec:0001651311). UBO chain traced 165 hops, 8 owners. Every claim linked to its source.
Ownership resolves 165 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- Merus N.V.
None in current sources.
165-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
Everything we hold on this subject, for one price — every hop to the ultimate owner, filing history, sanctions exposure, and the asset layer (property, vessels, aircraft) — as PDF and JSON, every claim linked to its source.
Everything we hold on Merus N.V., resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €99.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBODOSSIER
- Full export (PDF + un-redacted JSON) & change alertsDOSSIER
People & control
22 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- BIOTECHNOLOGY VALUE FUND II LPAlso holds roles at 100 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- AEOLUS PHARMACEUTICALS, INC.tenpercentowner
- BIOTECHNOLOGY VALUE FUND L PAlso holds roles at 105 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- AEOLUS PHARMACEUTICALS, INC.tenpercentowner
- Biotechnology Value Trading Fund OS LPAlso holds roles at 51 other companies
- XOMA Royalty Corpdirector
- Olema Pharmaceuticals, Inc.director
- XOMA Royalty Corpother
- BVF GP HOLDINGS LLCAlso holds roles at 47 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- XOMA Royalty Corptenpercentowner
- BVF I GP LLCAlso holds roles at 44 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- Kymera Therapeutics, Inc.director
- BVF II GP LLCAlso holds roles at 40 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- Kymera Therapeutics, Inc.other
- BVF INC/ILAlso holds roles at 107 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- ADVANCED MAGNETICS INCtenpercentownerother
- BVF PARTNERS L P/ILAlso holds roles at 110 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- ADVANCED MAGNETICS INCtenpercentownerother
- BVF Partners OS Ltd.Also holds roles at 51 other companies
- XOMA Royalty Corpdirector
- Olema Pharmaceuticals, Inc.director
- Olema Pharmaceuticals, Inc.other
- GOWEN MAXINEAlso holds roles at 7 other companies
- Aclaris Therapeutics, Inc.director
- Passage BIO, Inc.director
- ACERAGEN, INC.director
- HADDOCK JASONAlso holds roles at 2 other companies
- CODIAK BIOSCIENCES, INC.director
- ARRAY BIOPHARMA INCofficer
- INCYTE CORPAlso holds roles at 93 other companies
- Trotta Matteoofficer
- Flannelly Barry Pofficer
- Denton Sheila A.officer
- Iwicki Mark TAlso holds roles at 12 other companies
- Q32 Bio Inc.director
- Inhibikase Therapeutics, Inc.officer
- KALA BIO, Inc.officer
- LAMPERT MARK NAlso holds roles at 93 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- Kymera Therapeutics, Inc.director
- Lundberg Sven AnteAlso holds roles at 3 other companies
- Q32 Bio Inc.director
- Vor Biopharma Inc.director
- CRISPR Therapeutics AGofficer
- MEHRA ANANDAlso holds roles at 18 other companies
- Aclaris Therapeutics, Inc.director
- Galera Therapeutics, Inc.tenpercentowner
- NextCure, Inc.tenpercentowner
- PERRY GREGORY DAlso holds roles at 9 other companies
- KALA BIO, Inc.director
- FINCH THERAPEUTICS GROUP, INC.officer
- NOVELION THERAPEUTICS INC.officer
- PUCCI PAOLOAlso holds roles at 9 other companies
- WEST PHARMACEUTICAL SERVICES INCdirector
- Replimune Group, Inc.director
- TRILLIUM THERAPEUTICS INC.director
- SANDOR VICTORAlso holds roles at 5 other companies
- ADC Therapeutics SAdirector
- Kymera Therapeutics, Inc.director
- AbCellera Biologics Inc.director
22 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns Merus N.V.?
- What is Merus N.V.'s risk level?
- Where does Merus N.V. appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for Merus N.V. — nothing is disclosed before that.